The previous article examined how drug development has changed over the last century, whilst highlighting the theme of the increased complexity of drug development. In this follow-up article, Keith J. Williams and Bryan Hurst at Boyd Consultants looks at how many new drugs are being discovered within universities and start-up biotechnology companies. The general problems of sourcing and managing development resources, dealt with in this paper, apply to both of these types of organisations, though the actual development issues will differ.
[prettyfilelink src=”http://ipimediaworld.com/wp-content/uploads/2013/06/1-Virtual-Drug-Development.pdf” type=”pdf”]Virtual Drug Development[/prettyfilelink]
http://ipimediaworld.com/wp-content/uploads/2013/06/1-Virtual-Drug-Development.pdf